Bellicum Pharmaceuticals, Inc.

OTCPK:BLCM Stock Report

Market Cap: US$879.5k

Bellicum Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BLCM?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders116,8410.993%
Institutions456,1013.88%
Hedge Funds3,443,93129.3%
General Public7,748,66165.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 36.6%.


Top Shareholders

Top 12 shareholders own 34.14% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.1%
Baker Bros. Advisors LP
2,365,472US$176.8k0%no data
9.17%
Armistice Capital LLC
1,078,459US$80.6k12.8%no data
3.81%
Ikarian Capital, LLC
448,101US$33.5k0%0.01%
0.19%
Jon Stonehouse
22,054US$1.6k0%no data
0.17%
Reid Huber
19,494US$1.5k0%no data
0.16%
Stephen Davis
18,715US$1.4k0%no data
0.12%
Judith Klimovsky
14,602US$1.1k0%no data
0.12%
Charity Scripture
14,587US$1.1k0%no data
0.12%
James Daly
14,377US$1.1k0%no data
0.11%
Richard Fair
13,012US$972.60%no data
0.051%
Tekla Capital Management LLC
6,000US$448.50%no data
0.017%
Wetzel Investment Advisors, Inc.
2,000US$149.50%no data